Investigation Report on Recombinant Human Coagulation Factor VIII in China, 2018-2022

$2,200$3,300

Currently, recombinant human coagulation factor VIII sold on the Chinese market is all imported from Bayer, Baxalta and Wyeth. Bayer secures the highest market share, which was close to 68% in 2017.

Read more